Related Experiment Video

Updated: Aug 15, 2026

Development of a Neonatal Rat Model for Brachial Plexus Birth Injury
09:42

Development of a Neonatal Rat Model for Brachial Plexus Birth Injury

Published on: March 27, 2026

Botulinum toxin for treatment of cocontractions related to obstetrical brachial plexopathy

Carlos O Heise1, Lilian R Gonçalves, Egberto R Barbosa

  • 1Department of Neurology, University of São Paulo Medical School, São Paulo, SP, Brazil. carlos.heise@fleury.com.br

Arquivos De Neuro-Psiquiatria
|September 21, 2005
PubMed

Insights

Botulinum toxin type A offers promising results for improving elbow function in children with obstetrical brachial plexopathy, particularly when targeting triceps muscles for enhanced flexion.

Area of Science:

  • Neurology
  • Pediatrics
  • Rehabilitation Medicine

Background:

  • Obstetrical brachial plexopathy can lead to biceps-triceps muscle cocontraction, impairing elbow function in children.
  • Botulinum toxin type A is a novel therapeutic agent for this condition.

Observation:

  • Eight children with obstetrical brachial plexopathy were treated with botulinum toxin type A.
  • Injections were administered to biceps and/or triceps muscles at 2-3 U/kg, divided across multiple sites.

Findings:

  • Triceps injections resulted in sustained improvement in active elbow flexion for all treated patients.
  • Biceps injections provided temporary improvement in elbow extension for some patients, without achieving anti-gravitational strength.
  • One patient did not respond to triceps injections.

Implications:

  • Botulinum toxin type A shows potential as a treatment for persistent elbow dysfunction in pediatric obstetrical brachial plexopathy.
  • Targeting specific muscle groups, like the triceps, may yield more durable functional gains.
  • Further research is warranted to optimize treatment protocols and patient selection.

More Related Videos

Methods for In Vivo Biomechanical Testing on Brachial Plexus in Neonatal Piglets06:51

Methods for In Vivo Biomechanical Testing on Brachial Plexus in Neonatal Piglets

Published on: December 19, 2019

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...